Stay updated on SG vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the SG vs Docetaxel in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, reflecting a minor system/doc build update without changing study information.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed. This appears to be a minor update to the study documents without changing the study design or eligibility.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Yellowplace, Turkey (Türkiye) as a trial site and removed Sarıyer, Turkey (Türkiye) from the locations list.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.4.2 has been added. The previous v3.4.1 notice governing government funding and potential delays has been removed.SummaryDifference0.1%

Stay in the know with updates to SG vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.